Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited proposed to declare an interim dividend for Fiscal Year 2025 on the basis of RMB 24.50 (inclusive of taxes) for every ten (10) shares in the capital of the Company. The Proposed Interim Dividend is payable in respect of all issued shares in the capital of the Company as at the record date to be determined by the Company for the purposes of determining Shareholders' entitlements to the Proposed Interim Dividend. Subject to the Proposed Interim Dividend being approved by Shareholders at the 2025 2nd EGM, the Company will announce the record date and the payment date for the Proposed Interim Dividend in due course.